Skip to main content
KOREA ARLICO PHARM CO.,LTD. logo

KOREA ARLICO PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 260660 ISIN · KR7260660006 KO Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2026-02-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 260660

About KOREA ARLICO PHARM CO.,LTD.

https://jazzarlico.tradekorea.com/compa…

Korea Arlico Pharm Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes prescription (ETC) and over-the-counter (OTC) drugs, medical devices, and oriental medical preparations, with a specialization in generic pharmaceuticals. Operating from a KGMP-certified facility, it focuses on continuous innovation to improve human health. The company serves its domestic market and exports its products to numerous countries, with the goal of expanding its global presence.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically related to convertible bonds) by Kyobo Securities and its special related party. This type of filing is used to notify the market and regulators when a significant ownership threshold is crossed or changed. In the provided taxonomy, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels.
2026-02-12 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Aliko Pharmaceutical regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the board approval date. This aligns perfectly with the definition for 'Notice of Dividend Amount' (DIV).
2026-02-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Allico Pharmaceutical regarding a significant change in sales or profit/loss structure (30% or more). It provides a comparative table of financial results (revenue, operating profit, net income) between the current and previous fiscal years, along with detailed explanations for the variances. This is a standard 'Earnings Release' (ER) filing in the Korean market (DART system), which serves as the initial announcement of financial performance before the full audited annual report is finalized. FY 2025
2026-02-12 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from Aliko Pharmaceutical regarding the acquisition of convertible bonds before maturity (early redemption/put option). This falls under capital structure changes and financing updates, specifically related to debt instruments. Given the specific nature of the filing regarding the cancellation of debt securities, it fits best under the 'CAP' (Capital/Financing Update) category.
2026-02-10 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the completion of a private placement of convertible bonds (증권 발행결과). It details the issuance amount, payment date, and confirms the completion of the transaction initiated by a previous board resolution. This falls under the category of capital and financing updates.
2026-01-07 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It contains detailed terms of the financing, including interest rates, conversion prices, call/put options, and the use of proceeds. This falls under the category of capital and financing updates.
2025-12-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.